HBD, a Chinese provider of metal 3D printing products and solutions, has completed a Series C round led by China Life Private Equity Investment while biotech startup Degron Therapeutics has secured a Series A round.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
